TR201200213A2 - Kombine dozaj formları. - Google Patents

Kombine dozaj formları.

Info

Publication number
TR201200213A2
TR201200213A2 TR2012/00213A TR201200213A TR201200213A2 TR 201200213 A2 TR201200213 A2 TR 201200213A2 TR 2012/00213 A TR2012/00213 A TR 2012/00213A TR 201200213 A TR201200213 A TR 201200213A TR 201200213 A2 TR201200213 A2 TR 201200213A2
Authority
TR
Turkey
Prior art keywords
dosage forms
combined dosage
combined
risedronate
calcium
Prior art date
Application number
TR2012/00213A
Other languages
English (en)
Inventor
Bi̇lgi̇ç Mahmut
Original Assignee
Bi̇lgi̇ç Mahmut
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bi̇lgi̇ç Mahmut filed Critical Bi̇lgi̇ç Mahmut
Priority to TR2012/00213A priority Critical patent/TR201200213A2/tr
Publication of TR201200213A2 publication Critical patent/TR201200213A2/tr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0007—Effervescent
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/675—Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1611—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Packages (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Steroid Compounds (AREA)

Abstract

Mevcut buluş risedronat ve kalsiyum içeren dozaj formlarından oluşan tedavi paketine yöneliktir.
TR2012/00213A 2011-01-06 2012-01-06 Kombine dozaj formları. TR201200213A2 (tr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
TR2012/00213A TR201200213A2 (tr) 2011-01-06 2012-01-06 Kombine dozaj formları.

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
TR2011/00149A TR201100149A2 (tr) 2011-01-06 2011-01-06 Geliştirilmiş risedronat formülasyonu.
TR2012/00213A TR201200213A2 (tr) 2011-01-06 2012-01-06 Kombine dozaj formları.

Publications (1)

Publication Number Publication Date
TR201200213A2 true TR201200213A2 (tr) 2012-07-23

Family

ID=45787321

Family Applications (4)

Application Number Title Priority Date Filing Date
TR2011/00149A TR201100149A2 (tr) 2011-01-06 2011-01-06 Geliştirilmiş risedronat formülasyonu.
TR2012/00212A TR201200212A2 (tr) 2011-01-06 2012-01-06 Risedronat içeren geliştirilmiş formülasyonlar.
TR2012/00211A TR201200211A2 (tr) 2011-01-06 2012-01-06 Risedronat içeren farmasötik granüller.
TR2012/00213A TR201200213A2 (tr) 2011-01-06 2012-01-06 Kombine dozaj formları.

Family Applications Before (3)

Application Number Title Priority Date Filing Date
TR2011/00149A TR201100149A2 (tr) 2011-01-06 2011-01-06 Geliştirilmiş risedronat formülasyonu.
TR2012/00212A TR201200212A2 (tr) 2011-01-06 2012-01-06 Risedronat içeren geliştirilmiş formülasyonlar.
TR2012/00211A TR201200211A2 (tr) 2011-01-06 2012-01-06 Risedronat içeren farmasötik granüller.

Country Status (3)

Country Link
EP (1) EP2661258B1 (tr)
TR (4) TR201100149A2 (tr)
WO (1) WO2012093980A1 (tr)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL77243A (en) 1984-12-21 1996-11-14 Procter & Gamble Pharmaceutical compositions containing geminal diphosphonic acid compounds and certain such novel compounds
TR200900878A2 (tr) * 2009-02-05 2010-08-23 Bi̇lgi̇ç Mahmut Tek bir dozaj formunda kombine edilen farmasötik formülasyonlar

Also Published As

Publication number Publication date
EP2661258B1 (en) 2016-04-27
EP2661258A1 (en) 2013-11-13
TR201200211A2 (tr) 2012-07-23
TR201200212A2 (tr) 2012-07-23
TR201100149A2 (tr) 2012-07-23
WO2012093980A1 (en) 2012-07-12

Similar Documents

Publication Publication Date Title
CY1120730T1 (el) Απο του στοματος χορηγουμενη δοσολογια ενωσεων glp-1
UA110813C2 (uk) Лікування ліподистрофії
CO7111289A2 (es) Compuestos inhibidores de metaloenzimas
EP2670434A4 (en) TREATMENT OF TAUOPATHIES
EP2825898A4 (en) AUDIO SOURCE PROCESSING
EA201500314A1 (ru) Лекарственные формы энзалутамида
EA201590321A1 (ru) Дейтерированный барицитиниб
EA201391248A1 (ru) Биспецифические связывающие агенты
BR112013028512A2 (pt) cápsula
EA201590296A1 (ru) Дейтерированный ибрутиниб
EA201590272A1 (ru) Пероральные дозированные формы для модифицированного высвобождения, содержащие руксолитиниб
EA201300388A1 (ru) Соединения замещенного бензамида
UA116999C2 (uk) Виділене антитіло до гемаглютиніну та фармацевтична композиція, що його містить
HN2012000023A (es) Compuestos y composiciones para el tratamiento de enfermedades parasitarias
BR112013024211A2 (pt) tratamento de tumores sólidos
CO7141434A2 (es) Nueva forma de dosificación formulación de abediterol
ECSP14033284A (es) Composición herbicida que tiene actividad herbicida mejorada
EA201400165A1 (ru) Частицы на основе полиакрилата, которые содержат активное соединение
EA201790312A1 (ru) Комбинации лекарственных средств для лечения множественной миеломы
CO7020915A2 (es) Inhibidores de iap
EA201201296A1 (ru) Способы лечения диабетических язв стопы
BR112013026462A2 (pt) protetor de pé
GT201300041A (es) Composicion fungicida sinergista
EA201270728A1 (ru) Пуриновые соединения
EA201690075A1 (ru) Способ лечения внутриклеточной инфекции